The Respiratory Drugs Market growth continues to accelerate as the global push for environmental sustainability reshapes inhaler propellant technology and drives the transition from hydrofluoroalkane to greener alternatives. With traditional metered-dose inhalers contributing to greenhouse gas emissions through HFA propellants and facing increasing regulatory and consumer pressure, the demand...